Home > Healthcare > Medical Devices > Medical Supplies > Disposable Incontinence Products Market
Disposable Incontinence Products Market size was valued at USD 12.3 billion in 2022 and is expected to register over 7.4% CAGR between 2023 and 2032. This substantial market growth is pertaining to key factors such as the increasing occurrence of obesity, diabetes, ageing population, facilitative clinical initiatives, and technological developments associated with disposable incontinence products
The surged incidence of neurological conditions and incontinence is driving the demand for novel disposable incontinence products that is anticipated to compliment the business growth. This disease burden is expected to grow significantly in the near future due to factors such as aging population, urology, and endocrine disorders among others. Therefore, the above-mentioned factors are expected to increase the demand for disposable incontinence products in several healthcare settings
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Disposable Incontinence Products Market Size in 2022: | 12 Billion (USD) |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 7% |
2032 Value Projection: | 25 Billion (USD) |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 510 |
Tables, Charts & Figures: | 863 |
Segments covered: | Product, Application, Incontinence Type, Disease, Material, Gender, Age Group, Distribution Channel, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Disposable incontinence products are widely used by patients of all age groups as they have a substantial impact on the quality of user's life. Devices that possess least amount of risk are classified as class I medical devices, devices that possess moderate risk are considered as class II, while class III medical devices are perceived to possess highest risk associated with them. The U.S.FDA categorizes the disposable incontinence products as a class II medical devices and are covered under gastroenterology urology devices. Majority of the medical devices that are classified as class II devices by the U.S. FDA require 510(k) clearance to legally commercialize the product.